Sign up for the QMED & MD+DI Daily newsletter.
Challenge to Respond
January 1, 2002
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Challenge to Respond")
Originally Published MX January/February 2002
MARKET ANALYSIS
Challenge to Respond
According to Manoj Kenkare, research manager for the healthcare and life sciences practice at Frost & Sullivan (San Antonio, TX), the healthcare industry has many more challenges and limitations than it does drivers or positive forces. Even so, says Kenkare, "if all the medical technology companies and regulatory organizations were to work toward resolving the limitations and challenges, 2002 could offer healthy competition and excellent service opportunities for end-users and consumers." Following are some of the primary challenges and limitations that Kenkare says medtech companies and regulatory authorities should seek to understand and resolve.
Primary Challenges
Conquering new markets while preserving existing ones threatens brand loyalty.
Declining return on investment for end-users threatens revenues for manufacturers.
Continuing pressure on manufacturers brings high-technology products to market faster.
Asian manufacturers' cheap labor costs forces U.S. manufacturers to cut costs and quality.
Shortage of
You May Also Like
